{
    "id": 26309,
    "fullName": "RET E805K",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "RET E805K lies within the protein kinase domain of the Ret protein (UniProt.org). E805K demonstrates weak transforming ability in culture in one study (PMID: 17047083) and therefore, is predicted to lead to a gain of Ret protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 8498,
                    "pubMedId": 17047083,
                    "title": "RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17047083"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5979,
        "geneSymbol": "RET",
        "terms": [
            "RET",
            "CDHF12",
            "CDHR16",
            "HSCR1",
            "MEN2A",
            "MEN2B",
            "MTC1",
            "PTC",
            "RET-ELE1"
        ]
    },
    "variant": "E805K",
    "createDate": "04/08/2017",
    "updateDate": "10/17/2018",
    "referenceTranscriptCoordinates": {
        "id": 125281,
        "transcript": "NM_020975",
        "gDna": "chr10:g.43119551G>A",
        "cDna": "c.2413G>A",
        "protein": "p.E805K",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 13694,
            "approvalStatus": "Guideline",
            "evidenceType": "Risk Factor",
            "efficacyEvidence": "Compound germline RET V840M and E805K mutations result in multiple endocrine neoplasia, type 2B (MEN 2B), which is associated with high risk of developing thyroid medullary carcinoma (NCCN.org).",
            "molecularProfile": {
                "id": 29380,
                "profileName": "RET V804M RET E805K"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 3973,
                "name": "thyroid gland medullary carcinoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27511,
            "profileName": "RET E805K",
            "profileTreatmentApproaches": [
                {
                    "id": 11194,
                    "name": "RET Inhibitor",
                    "profileName": "RET E805K"
                }
            ]
        },
        {
            "id": 29380,
            "profileName": "RET V804M RET E805K",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 125282,
            "transcript": "NM_020630",
            "gDna": "chr10:g.43119551G>A",
            "cDna": "c.2413G>A",
            "protein": "p.E805K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 125281,
            "transcript": "NM_020975",
            "gDna": "chr10:g.43119551G>A",
            "cDna": "c.2413G>A",
            "protein": "p.E805K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}